Topical Anti-Inflammatory Treatments for Atopic Dermatitis.
meta_analysis · Level I
Where this comes from
- Record sourced from PubMed, PMID 41160034.
- Also identified by DOI 10.1001/jamadermatol.2025.3986.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Which topical anti-inflammatory treatments are most effective and safe for managing atopic dermatitis? In a network meta-analyses, very potent/potent topical corticosteroids; tacrolimus, 0.1%; and topical Janus kinase inhibitors were among the most effective treatments for short-term control of atopic dermatitis symptoms, while phosphodiesterase-4 inhibitors were among the least effective. Topical calcineurin inhibitors and crisaborole were associated with application-site irritation, and short-term topical steroid use was not associated with skin thinning. However, these findings were of low to moderate certainty, and longer-term data remain limited for many agents.
Medical subject headings
- Anti-Inflammatory Agents
- Dermatitis, Atopic